Skip to content
Latest News
Huaneng (HNP) Stock Rallied 6.5% After Launching a 320MW Floating Solar Plant

Key points: Huaneng Power just commissioned a solar power plant with a 320 MW capacity. The project is the largest floating PV project in the world. China is n

Simon Mugo
You Might Not Want To Take Tesla’s ‘Impressive Deliveries’ For Face Value

Tesla' 'Blockbuster Q4 deliveries' doesn't quite tell the whole story Due to safety issues, nearly half a million models were recalled Tesla is up 10% and approaches 2021 high's as investors latch on to Q4 positivi

Ollie Martin - AskTraders News writer
OllieMartin
Here’s Why Xeris Biopharma (XERS) Stock Price Barely Moved Despite Raising $30M

Key points: Xeris Biopharma stock price barely moved despite raising $30m. Shareholders were okay with the dilution since they sold the shares at cost. The sto

Simon Mugo
Chinese Buyers Flock to Nio, Xpeng & More To Avoid 2022 Subsidy Cuts

The Chinese market continues to dominate the NEV market, breeding competition amidst changing government subsidies Nio posted a record Q4 and Xpeng recorded the highest number of December sales amongst all manufacturers

Ollie Martin - AskTraders News writer
OllieMartin
Immix Biopharma (IMMX) Stock Surged 138.7% on FDA Rare Drug Designation

Key points: Immix Bio’s IMX-110 was granted Rare Pediatric Disease Designation (RPDD). The drug also has an orphan drug designation from the FDA to treat soft tissue carcinoma.

Simon Mugo
Here’s Why Creative Medical Tech (CELZ) Stock Price Soared 96.4% Premarket

Key points: CELZ stock rallied 96.4% premarket despite a lack of releases. The rally was primarily driven by positive investor sentiment. As a result, the biot

Simon Mugo
GameStop Stock Ends the Year Up 724%. So What’s Next for the Meme Stock?

Key points: Gamestop stock is set to end the year up 724%. However, the company is yet to unveil a clear transformation plan. As a result, it is risky to inves

Simon Mugo
Xeris Biopharma (XERS) Stock Surged 26.3% After the FDA Approved Its Recorlev Drug

Key points: The FDA approved Xeris Biopharma endogenous hypercortisolemia drug today. The drug (Recorlev) treats patients with Cushing’s syndrome who cannot have surgery.

Simon Mugo
Peloton Stock Downgraded Further by JPMorgan Analyst. Will It Rally in 2022?

Key points: Peloton shares were downgraded to Market Perform by a JP Morgan analyst. Nevertheless, the exercise equipment manufacturer’s prospects are pretty positive.

Simon Mugo
The Powerhouse Energy (PHE) Share Price Fell 54.1% in 2021. So what’s Next in 2022?

Key points: Powerhouse Energy is a hydrogen energy firm whose shares fell 54.1% in 2021. The company generates hydrogen from a waste gasification process. PHE’

Simon Mugo
Vela Shares Barely Moved After Releasing Its Half-Year Trading Update. Is It a Buy?

Key points: Vela Technologies released a trading update for the first half of its fiscal year. The markets barely reacted to the release as its share remained stable.

Simon Mugo
Tesla Is Off 2% On News Of Product Recall

Tesla is to recall near 500,000 vehicles to correct manufacturing faults This is not a killer blow but it does emphasise the difficulties of manufacturing

Tim Worstall
Tim Worstall
Savannah Energy Jumps 25% On Relisting

Savannah Energy deals in oil and gas in Nigeria and Niger Gas is booming in price so this is good, right? 

Tim Worstall
Tim Worstall
Supply@Me Capital (SYME) Shares Crashed 28.3% on H2 Trading Update. What’s Next?

Key points: Supply@Me Capital released a trading update for the second half of 2021. Unfortunately, investors reacted negatively to the report, evidenced by the decline.

Simon Mugo
Kodal Minerals Remains Volatile On Market Sentiment

Kodal Minerals is down 10% this morning following its near 50% rise from recent lows Junior miners like Kodal simply are volatile, it’s an effect of the ba

Tim Worstall
Tim Worstall
Biogen Down 8% on Denied Rumours of Acquisition from Samsung

Rumors surrounding an acquisition from Samsung sent Biogen stock soaring 9.5% on Wednesday With the rumours denounced as 'false', stock tanked around 8% in early Thursday trading.  

Ollie Martin - AskTraders News writer
OllieMartin
New Annual Lows For Nio as Omicron Spurs Sell-Off, What’s Next?

Nio extends downside with Omicron selling wave The EV stock has lost almost 50% of its market cap since publically trading With Nio Day outlining growth potential, what will 2022 bring for the company?

Ollie Martin - AskTraders News writer
OllieMartin
Johnson & Johnson Stock Edges Higher as Vaccine Proves 85% Effective

JNJ stock edges higher on positive data from South African vaccine study 2 doses offer 85% protection against Omicron hospitalization The J&J vaccine may also act as a booster for the Pfizer shot.

Ollie Martin - AskTraders News writer
OllieMartin
Future Fintech (FTFT) Stock Spiked 39.8% After Creating a New Blockchain Division

Key points: Future Fintech just unveiled a new blockchain business division. The unit will handle the company’s blockchain and cryptocurrency businesses. The d

Simon Mugo
Citi Resume Buy Rating of Lucid Group Despite Rivian Supply Ripples

Worries brew amongst EV stocks following Rivian delays Citi Bank issue a buy rating and price target of $57 for LCID stock Hopes for Lucid rest on the launch of the Lucid Air, set for later this year &

Ollie Martin - AskTraders News writer
OllieMartin
Analysis Stocks Markets Strategies